Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

51° Mostly Cloudy
- Saint Marys, OH (45885)
  Today
  
  Mostly cloudy skies this morning will become partly cloudy this afternoon. Slight chance of a rain shower. High near 55F. Winds WNW at 15 to 25 mph..
  
  Tonight
  
  A few clouds. Low 24F. Winds NNW at 10 to 15 mph.
  
  Updated: April 6, 2026 @ 12:13 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Best of 2026

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bayer Ag ADR (OP:BAYRY)

11.35 +0.09 (+0.81%)

Streaming Delayed Price Updated: 1:43 PM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 Next >

AI Meets Biotech: 3 Top Stocks Transforming Medical Science ↗

December 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

Via InvestorPlace

Topics Artificial Intelligence

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss ↗

December 06, 2023

Bayer AG (OTC: BAYRY) (OTC:

Via Benzinga

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion ↗

December 04, 2023

The spotlight is on a Philadelphia trial as Bayer AG (OTC: BAYRY) (OTC: BAYZF) grapples with mounting legal challenges surrounding its Roundup weedkiller, prompted by multi-billion dollar verdicts

Via Benzinga

Topics Lawsuit

PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out ↗

November 28, 2023

Big chemical companies won a lawsuit preventing 11.8 million Ohio residents from suing them for PFAS chemicals in their blood.

Via Benzinga

Topics Lawsuit

3 Battered Blue-Chip Stocks to Sell in December ↗

November 28, 2023

Steer clear of these once flourishing companies, each of which has problems they need to overcome before their share price rises again.

Via InvestorPlace

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks ↗

November 24, 2023

Bayer AG (OTC: BAYRY) (OTC: BAYZF) reportedly held an investor call to address concerns after intense scrutiny from investors following a series of unforeseen setbacks, prompting questions about...

Via Benzinga

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence ↗

November 20, 2023

Monday, Bayer AG (OTC: BAYRY) (OTC: BAYZF)

Via Benzinga

Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details ↗

November 20, 2023

Bayer AG (OTC: BAYRY) (OTC: BAYZF)

Via Benzinga

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits ↗

November 17, 2023

The Delaware Supreme Court reportedly ruled in favor of Bayer AG (OTC: BAYRY) (OTC: BAYZF), stating that the company is not accountable for lawsuits associated with talc-based foot powder products...

Via Benzinga

Topics Lawsuit

Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss ↗

November 08, 2023

Bayer AG (OTC: BAYRY) (OTC: BAYZF) CEO Bill Anderson announced

Via Benzinga

Earnings Review: Bayer To Make Strategic Changes After Q3 Results ↗

November 08, 2023

The latest financial statements from Bayer Group show a year-over-year decline in several key areas, painting a stark picture of the company’s fiscal health.

Via Talk Markets

Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss ↗

November 01, 2023

Bayer AG (OTC: BAYRY) (OTC:

Via Benzinga

Cathie Wood’s Stock Shuffle: 4 Names She’s Loving, 3 She’s Leaving ↗

September 27, 2023

Investors tend to closely watch which Cathie Wood stocks are bought and sold as she has history of generating big returns in her ETFs

Via InvestorPlace

AI To Revolutionize Clinical Trials And Diagnostics ↗

September 22, 2023

With the help of technology, the pharmaceutical industry is gaining new insights that are fueling the development of next generation of drugs while also speeding up clinical trials and improving...

Via Benzinga

Topics Artificial Intelligence

From Years to Months: How AI is Shaping the Landscape of Clinical Trials ↗

September 22, 2023

Pharmaceutical companies are harnessing artificial intelligence (AI) to speed up the traditionally arduous process of clinical trials, potentially saving both time and significant sums of money. These...

Via Benzinga

Topics Artificial Intelligence

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

Via Benzinga

Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories ↗

August 28, 2023

Reuters

Via Benzinga

German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals ↗

August 28, 2023

Boston Scientific Corporation (NYSE: BSX) released 12-month results from the pivotal ADVENT trial of the FARAPULSE Pulsed Field Ablation (PFA) System, a nonthermal treatment in which electric fields...

Via Benzinga

FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness ↗

August 21, 2023

The FDA approved Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) approved Eylea HD (aflibercept) Injection 8 mg for wet age-related macular degeneration (wAMD), diabetic macular edema (DME),

Via Benzinga

As Tiziana Life Sciences (NASDAQ: TLSA) Prepares For Phase 2 Trials, Have They Successfully Derisked Foralumab? ↗

August 08, 2023

Tiziana Life Sciences, Inc.

Via Benzinga

Regeneron Pharma Says Fewer Aflibercept Injections Maintains Vision, Anatomic Improvements In Diabetic Macular Edema ↗

July 31, 2023

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the first presentation of two-year (96 weeks) results from the pivotal PHOTON trial of aflibercept 8 mg with 12- and 16-week dosing regimens,...

Via Benzinga

Phase 1 Results Are "Extraordinary," Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment ↗

July 17, 2023

Tiziana Life Sciences (NASDAQ: TSLA) has presented data from its clinical trial showing that five of its six patients with an advanced stage of multiple sclerosis (MS) have shown a reduction in...

Via Benzinga

AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer ↗

June 29, 2023

AstraZeneca Plc (NASDAQ: AZN) released updated results from the HIMALAYA Phase 3 trial evaluating Imfinzi (durvalumab) plus Imjudo (tremelimumab-actl) in unresectable hepatocellular carcinoma (HCC)...

Via Benzinga

Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study ↗

June 28, 2023

Bayer AG (OTC: BAYRY) (OTC: BAYZF) and its subsidiary BlueRock Therapeutics LP announced

Via Benzinga

Experimental Stem Cell Therapy For Parkinson's Shows Promise in Phase I Trial: Reuters ↗

June 28, 2023

Via Benzinga

Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender ↗

June 27, 2023

The FDA still needs to review its inspection of a third-party facility, Regeneron said late Tuesday.

Via Investor's Business Daily

Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst ↗

June 23, 2023

Raymond James has initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN) with an Outperform rating and a

Via Benzinga

Unmasking Q2 2023's Stars & Strugglers: Industry ETFs And Top Stock Standouts ↗

June 27, 2023

Via Benzinga

There’s Only One Way To Beat The Market ↗

June 12, 2023

The way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. Today, I want to show you how savvy stock pickers can profit from...

Via Talk Markets

Perrigo Picks Former Bayer Executive As New CEO ↗

June 08, 2023

Perrigo Co PLC (NYSE: PRGO) disclosed the appointment of Patrick Lockwood-Taylor as its new President, CEO and member of the Board of Directors,

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Business
Announcements
Obituaries
Local Events
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Evening Leader

theeveningleader.com
102 E. Spring St.
Saint Marys, Ohio 45885
Phone: 419-394-7414
Email: editor@theeveningleader.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Saint Marys, OH (45885)

Today

Tonight

Bayer Ag ADR (OP:BAYRY)

All News about Bayer Ag ADR

Sections

Services

The Evening Leader